Carocell Bio

Carocell Bio are developing novel anti-inflammatory peptides to more safely treat inflammatory diseases.  Our lead (JEL3108) is to more safely treat atopic dermatitis (AD, eczema), prevent its recurrence and possibly delay ageing of the skin.

Contact us

Contact

London BioScience Innovation Centre
2 Royal College Street
London
NW1 0NH
United Kingdom

Tel: +44 (0) 20 7691 1122

Connect with us